Aequitas Research - Genetron (泛生子) Pre-IPO - Positive product development but tracking behind Burning Rock: Genetron, a China-based precision oncology company, plans to raise up to USD 150 million to list in the US. In our previous… https://t.co/4qcMpfja2O #equity #stocks